Similar to anti-gout agent colchicine, EC could also significantly suppress protein the overexpression of NLRP3 inflammasome and the NF-κB pathway in ankle joint tissues (Figure 7A, 7B), as well as the protein expression of p-p65 in the nucleus (Figure 7C). Here, NLRP3 is linked to gout.